Loading...
Loading...

by Intas Pharmaceuticals Ltd· 1S
SKU: 967650
You save ₹186 on this order
Inclusive of all taxes
TERIFRAC MULTI PEN(DEVICE) is used in the management of osteoporosis. It
contains a medicine called teriparatide which is an anabolic agent that is used
to make the bones stronger, and to reduce the risk of fractures by stimulating
bone formation.
TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation.
TERIFRAC MULTI PEN(DEVICE) is not recommended for use in pregnant or
breastfeeding women. It is also not recommended for use in patients with Paget’s
disease, bone cancer or other cancers, certain bone diseases and hypercalcemia.
The most common side effects of TERIFRAC MULTI PEN(DEVICE) are dizziness, leg
cramps, mild headache, tachycardia, hypercalcemia symptoms such as nausea,
vomiting, constipation, low energy, or muscle weakness. Consult your doctor if
any of the above side effects worsens or persists for a longer duration.
TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone cells by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation. It also increases the thickness
of bone and rebuilds bones which reduces the risk of spine and hip fractures.
!### Pregnancy
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is generally not recommended for use in pregnant
women. Therefore, consult your doctor before receiving the medicine.
!### Breastfeeding
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is not recommended for use in breastfeeding women.
Consult your doctor before receiving the medicine.
!### Driving and Using Machines
ContraindicatedDo not drive or operate any machines if your ability is affected by TERIFRAC
MULTI PEN(DEVICE).
!### Alcohol
Consult your doctorAvoid consum
it might increase dizziness.
!### Allergy
ContraindicatedDo not receive TERIFRAC MULTI PEN(DEVICE) if you are allergic to Teriparatide or
any other ingredients of this medicine.
!### Use In Pediatrics
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is not recommended for use in children and adolescent
(below 18 years), Proper dose adjustments and careful monitoring are required in
such patients.
!### Use In Geriatrics
Use with CautionTERIFRAC MULTI PEN(DEVICE) should be used with caution in elderly patients (65
years and above). Consult your doctor before receiving the medicine.
TERIFRAC MULTI PEN(DEVICE) is not recommended for use if you:
A. Drug-Drug interactions:
Tell your doctor about all the medicines you are taking including prescri
non-prescri
Overdosage:
TERIFRAC MULTI PEN(DEVICE) will be administered to you only by a doctor or a
nurse in a hospital, and so it is unlikely to receive an overdose. However,
consult your doctor or nurse if you experience any unpleasant symptoms.
| Drug | : | Teriparatide |
| Pharmacological Category | : | Parathyroid hormone, Analogs |
| Therapeutic Indication | : | Osteoporosis |
| Dosage Forms | : | Injection, PFS, Cartridge |
A: TERIFRAC MULTI PEN(DEVICE) is generally not recommended for individuals with
a history of cancer, especially skeletal malignancies or bone metastases. The
medication has been associated with an increased risk of osteosarcoma, and its
safety in individuals with a history of cancer has not been well established.
A: Yes. TERIFRAC MULTI PEN(DEVICE) can be used in men with osteoporosis. While
Osteoporosis is more commonly associated with women, men can also develop the
condition. It can effectively increase bone density and reduce fracture risk in
men with osteoporosis.
A: TERIFRAC MULTI PEN(DEVICE) is commonly prescribed for individuals with a
history of fragility fractures. Fragility fractures occur due to minimal trauma
or impact and are often associated with osteoporosis. It helps to increase bone
density and reduce the risk of future fractures in individuals with
osteoporosis, including those who have previously experienced fractures.
A: TERIFRAC MULTI PEN(DEVICE) is typically not used as a first-line treatment
for osteoporosis. It is usually considered when other osteoporosis medications
are ineffective, or individuals have a high fracture risk. However, whether it
is appropriate as a first-line treatment depends on individual factors and
should be discussed with your healthcare provider.
A: The long-term effects of TERIFRAC MULTI PEN(DEVICE) have yet to be well
understood, particularly beyond the recommended treatment duration of 2 years.
The risk of osteosarcoma, a potential rare side effect, is one of the main
concerns associated with long-term use.
A: TERIFRAC MULTI PEN(DEVICE) should not be taken for longer than 2-year course.
It is important to inform the doctor if you have taken this medication in the
past, as you should not receive more than one treatment of 24 months course more
than once in your lifetime.
A: TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation. It also increases the thickness
of bone and rebuilds bones which reduces the risk of spine and hip fractures.
A: Yes. TERIFRAC MULTI PEN(DEVICE) may cause dizziness in some individuals. Try
to rest and relax. Get enough sleep. Avoid driving or operating machinery if you
feel dizziness. Avoid alcohol consum
your doctor if the symptom does not improve.
A: TERIFRAC MULTI PEN(DEVICE) is not recommended for use in children and
adolescents (below 18 years). Proper dose adjustments and careful monitoring are
required in such patients.
A: TERIFRAC MULTI PEN(DEVICE) will be given to you only by a doctor or a nurse
subcutaneously into the thigh or abdominal wall. Your doctor will decide the
correct dose and duration for you depending upon your age, body weight, and
disease condition.
TERIFRAC MULTI PEN(DEVICE) is used in the management of osteoporosis. It
contains a medicine called teriparatide which is an anabolic agent that is used
to make the bones stronger, and to reduce the risk of fractures by stimulating
bone formation.
TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation.
TERIFRAC MULTI PEN(DEVICE) is not recommended for use in pregnant or
breastfeeding women. It is also not recommended for use in patients with Paget’s
disease, bone cancer or other cancers, certain bone diseases and hypercalcemia.
The most common side effects of TERIFRAC MULTI PEN(DEVICE) are dizziness, leg
cramps, mild headache, tachycardia, hypercalcemia symptoms such as nausea,
vomiting, constipation, low energy, or muscle weakness. Consult your doctor if
any of the above side effects worsens or persists for a longer duration.
TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone cells by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation. It also increases the thickness
of bone and rebuilds bones which reduces the risk of spine and hip fractures.
!### Pregnancy
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is generally not recommended for use in pregnant
women. Therefore, consult your doctor before receiving the medicine.
!### Breastfeeding
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is not recommended for use in breastfeeding women.
Consult your doctor before receiving the medicine.
!### Driving and Using Machines
ContraindicatedDo not drive or operate any machines if your ability is affected by TERIFRAC
MULTI PEN(DEVICE).
!### Alcohol
Consult your doctorAvoid consum
it might increase dizziness.
!### Allergy
ContraindicatedDo not receive TERIFRAC MULTI PEN(DEVICE) if you are allergic to Teriparatide or
any other ingredients of this medicine.
!### Use In Pediatrics
ContraindicatedTERIFRAC MULTI PEN(DEVICE) is not recommended for use in children and adolescent
(below 18 years), Proper dose adjustments and careful monitoring are required in
such patients.
!### Use In Geriatrics
Use with CautionTERIFRAC MULTI PEN(DEVICE) should be used with caution in elderly patients (65
years and above). Consult your doctor before receiving the medicine.
TERIFRAC MULTI PEN(DEVICE) is not recommended for use if you:
A. Drug-Drug interactions:
Tell your doctor about all the medicines you are taking including prescri
non-prescri
Overdosage:
TERIFRAC MULTI PEN(DEVICE) will be administered to you only by a doctor or a
nurse in a hospital, and so it is unlikely to receive an overdose. However,
consult your doctor or nurse if you experience any unpleasant symptoms.
| Drug | : | Teriparatide |
| Pharmacological Category | : | Parathyroid hormone, Analogs |
| Therapeutic Indication | : | Osteoporosis |
| Dosage Forms | : | Injection, PFS, Cartridge |
A: TERIFRAC MULTI PEN(DEVICE) is generally not recommended for individuals with
a history of cancer, especially skeletal malignancies or bone metastases. The
medication has been associated with an increased risk of osteosarcoma, and its
safety in individuals with a history of cancer has not been well established.
A: Yes. TERIFRAC MULTI PEN(DEVICE) can be used in men with osteoporosis. While
Osteoporosis is more commonly associated with women, men can also develop the
condition. It can effectively increase bone density and reduce fracture risk in
men with osteoporosis.
A: TERIFRAC MULTI PEN(DEVICE) is commonly prescribed for individuals with a
history of fragility fractures. Fragility fractures occur due to minimal trauma
or impact and are often associated with osteoporosis. It helps to increase bone
density and reduce the risk of future fractures in individuals with
osteoporosis, including those who have previously experienced fractures.
A: TERIFRAC MULTI PEN(DEVICE) is typically not used as a first-line treatment
for osteoporosis. It is usually considered when other osteoporosis medications
are ineffective, or individuals have a high fracture risk. However, whether it
is appropriate as a first-line treatment depends on individual factors and
should be discussed with your healthcare provider.
A: The long-term effects of TERIFRAC MULTI PEN(DEVICE) have yet to be well
understood, particularly beyond the recommended treatment duration of 2 years.
The risk of osteosarcoma, a potential rare side effect, is one of the main
concerns associated with long-term use.
A: TERIFRAC MULTI PEN(DEVICE) should not be taken for longer than 2-year course.
It is important to inform the doctor if you have taken this medication in the
past, as you should not receive more than one treatment of 24 months course more
than once in your lifetime.
A: TERIFRAC MULTI PEN(DEVICE) works by causing the body to build new bone by
increasing bone strength and bone mass density (BMD) (thickness) and reduce the
risk of fractures by stimulating bone formation. It also increases the thickness
of bone and rebuilds bones which reduces the risk of spine and hip fractures.
A: Yes. TERIFRAC MULTI PEN(DEVICE) may cause dizziness in some individuals. Try
to rest and relax. Get enough sleep. Avoid driving or operating machinery if you
feel dizziness. Avoid alcohol consum
your doctor if the symptom does not improve.
A: TERIFRAC MULTI PEN(DEVICE) is not recommended for use in children and
adolescents (below 18 years). Proper dose adjustments and careful monitoring are
required in such patients.
A: TERIFRAC MULTI PEN(DEVICE) will be given to you only by a doctor or a nurse
subcutaneously into the thigh or abdominal wall. Your doctor will decide the
correct dose and duration for you depending upon your age, body weight, and
disease condition.